| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
SYBX sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 29, 2025 | Dooley Mary Beth63 | See Remarks Below | Sell | 157 | $1.81 | $284.17 | -1.2% | - | - | |
| Apr 2, 2025 | Dooley Mary Beth63 | See Remarks Below | Sell | 144 | $1.20 | $172.80 | -1.1% | -1.7% | -50.4% | |
| Feb 3, 2025 | Dooley Mary Beth63 | See Remarks Below | Sell | 2,107 | $1.33 | $2,802.31 | -13.9% | -11.4% | - | |
| Oct 29, 2024 | Dooley Mary Beth63 | Head of Finance | Sell | 79 | $1.40 | $110.60 | -0.5% | -2.7% | +21.2% | |
| Apr 2, 2024 | Dooley Mary Beth63 | Head of Finance | Sell | 188 | $1.73 | $325.24 | -1.2% | -15.3% | -31.8% | |
| Apr 2, 2024 | Awad Antoine77 | Chief Operating Officer | Sell | 372 | $1.73 | $643.56 | -1.1% | -15.3% | -31.8% | |
| Apr 3, 2023 | Awad Antoine77 | Chief Operating Officer | Sell | 6,438 | $0.58 | $3,707.00 | -7.9% | -29.4% | -79.8% | |
| Apr 3, 2023 | Brennan Aoife58 | See Remarks | Sell10b5-1 | 19,042 | $0.58 | $10,964.38 | -6.9% | -29.4% | -79.8% | |
| Apr 3, 2023 | Jensen Michael Vangsted | Chief Financial Officer | Sell | 2,553 | $0.58 | $1,470.02 | -5.2% | -29.4% | -79.8% | |
| May 24, 2022 | Jensen Michael Vangsted | Chief Financial Officer | Buy | 9,500 | $1.12 | $10,640.00 | +31.7% | -11.4% | -49.1% |